T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Cooper Companies
COO
$13.6B
| $26.7M | ﹤0.01% |
281,888
+4,172
| +2% | +$395K |
|
877
Iovance Biotherapeutics
IOVA
$876M
| $26.6M | ﹤0.01% |
3,276,602
-320,518
| -9% | -$2.61M |
|
878
BridgeBio Pharma
BBIO
$10.1B
| $26.6M | ﹤0.01% |
658,362
+596,386
| +962% | +$24.1M |
|
879
Coty
COTY
$3.6B
| $26.6M | ﹤0.01% |
2,139,559
-536,565
| -20% | -$6.66M |
|
880
Genuine Parts
GPC
$19.9B
| $26.6M | ﹤0.01% |
191,800
-34,582
| -15% | -$4.79M |
|
|
PRFT
881
DELISTED
Perficient Inc
PRFT
| $26.4M | ﹤0.01% |
401,810
-13,458
| -3% | -$886K |
|
882
Rhythm Pharmaceuticals
RYTM
$6.5B
| $26.3M | ﹤0.01% |
572,297
+361,945
| +172% | +$16.6M |
|
883
Waters Corp
WAT
$18B
| $26.3M | ﹤0.01% |
79,778
+1,853
| +2% | +$610K |
|
884
Sapiens International
SPNS
$2.4B
| $26.2M | ﹤0.01% |
905,943
-30,196
| -3% | -$874K |
|
885
Invitation Homes
INVH
$18.8B
| $26.2M | ﹤0.01% |
767,892
+10,847
| +1% | +$370K |
|
886
ServisFirst Bancshares
SFBS
$4.63B
| $26M | ﹤0.01% |
389,817
+56,626
| +17% | +$3.77M |
|
887
Invesco
IVZ
$10.1B
| $25.7M | ﹤0.01% |
1,439,073
+52,881
| +4% | +$943K |
|
888
SolarEdge
SEDG
$1.75B
| $25.7M | ﹤0.01% |
274,024
+195,580
| +249% | +$18.3M |
|
|
WBA
889
DELISTED
Walgreens Boots Alliance
WBA
| $25.4M | ﹤0.01% |
971,897
+26,854
| +3% | +$701K |
|
890
Rollins
ROL
$28.2B
| $25.4M | ﹤0.01% |
580,747
+24,679
| +4% | +$1.08M |
|
891
Labcorp
LH
$23.2B
| $25.4M | ﹤0.01% |
111,554
-5,680
| -5% | -$1.29M |
|
892
HEICO
HEI
$44.7B
| $25.2M | ﹤0.01% |
140,727
+2,796
| +2% | +$500K |
|
893
Patrick Industries
PATK
$3.79B
| $25.1M | ﹤0.01% |
375,722
+61,026
| +19% | +$4.08M |
|
894
Carnival Corp
CCL
$44B
| $25M | ﹤0.01% |
1,345,937
+5,470
| +0.4% | +$101K |
|
895
Glaukos
GKOS
$5.02B
| $25M | ﹤0.01% |
313,924
+287,736
| +1,099% | +$22.9M |
|
896
NetApp
NTAP
$25B
| $24.9M | ﹤0.01% |
282,536
+3,116
| +1% | +$275K |
|
897
MGM Resorts International
MGM
$9.62B
| $24.9M | ﹤0.01% |
557,476
-22,303
| -4% | -$997K |
|
898
iShares US Home Construction ETF
ITB
$3.33B
| $24.9M | ﹤0.01% |
244,799
| – | – |
|
899
Green Brick Partners
GRBK
$3.28B
| $24.9M | ﹤0.01% |
479,109
+246,310
| +106% | +$12.8M |
|
900
Immuneering
IMRX
$341M
| $24.8M | ﹤0.01% |
3,378,100
-155,222
| -4% | -$1.14M |
|